U.S. Infant Deaths Rose After Fall of Roe v. Wade

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 21, 2024.

By Ernie Mundell HealthDay Reporter

MONDAY, Oct. 21, 2024 -- The United States experienced a small but significant rise in infant deaths in the months following the U.S. Supreme Court's decision overturned Roe v. Wade, a new study shows.

The Dobbs ruling, handed down in July of 2022, led to outright bans on abortion in 14 states and tighter restrictions in eight others.

According to researchers, forcing women to carry "frail fetuses" to term -- for example, fetuses with known congenital abnormalities -- might lead to more deaths in infancy.

That appears to be the case.

Looking at U.S. Centers for Disease Control and Prevention data on infant deaths for the years 2018 through 2023, the researchers observed a 7% rise in infant deaths in the months following the Dobbs decision, compared to the years before.

There was an even higher 10% rise in deaths for infants who died from congenital abnormalities.

The study, published Oct. 21 in the journal JAMA Pediatrics, was co-authored by Maria Gallo and Parvati Singh, a professor and an assistant professor of epidemiology, respectively, at Ohio State University.

The new data shouldn't come as a surprise, the researchers said, since it echoes findings from a study published earlier this year. That research revealed a rise in infant deaths in Texas after that state passed legislation in 2021 that essentially banned abortion.

Following that legislation, the rate of infant deaths in Texas rose by almost 13%, the study found.

The new study suggests similar trends are now happening nationwide, with the 7% increase equaling 247 excess deaths to U.S. babies during the months following the fall of Roe v. Wade, Gallo and Singh calculated.

Many of these added tragedies are "potentially owing to frail fetuses more often being carried to term following the implementation of abortion restrictions," they wrote.

Sources

  • JAMA Pediatrics, Oct. 21, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-10-22 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords